IGTP in 2025: 12 selected news stories
We look back at the year's most significant news stories, showcasing the dedication and collaboration that define IGTP.
At the IGTP TODAY
We look back at the year's most significant news stories, showcasing the dedication and collaboration that define IGTP.
The Germans Trias i Pujol Research Institute has secured €13,208,000 through several funding calls supporting research projects and research activity, the results of which were announced this December, including both Spanish and Catalan-level calls.
On 11 December, IGTP celebrated its 30th anniversary with an institutional and Christmas event that brought together professionals from across the Institute in a space for recognition, remembrance, and looking ahead to the future.
The Talents Grants for the 2024 and 2025 editions have been granted by the Fundació Catalunya La Pedrera, supporting healthcare professionals in developing research projects that will lead to their doctoral theses. This initiative, originally created through a collaboration with the Research Institute and Hospital Germans Trias i Pujol, now also includes Hospital Clínic Barcelona, the Vall d'Hebron Institute of Oncology and Hospital de Bellvitge.
IGTP has obtained funding for six projects, consolidating its trajectory in the field of biomedical and translational research on respiratory diseases. These projects, which address challenges such as tuberculosis, pulmonary fibrosis and legionellosis, represent the excellence and diversity of the research developed at the Can Ruti Campus.
The event gathered more than 200 researchers, reviewing the Institute's scientific trajectory and looking ahead to the future of research and innovation at the Can Ruti Campus.
The Fisabio Foundation, an organisation under the Department of Health, and IGTP have signed a framework agreement for scientific collaboration to jointly promote research in the field of AI and radiomics
The demonstration of the vaccine's efficacy in its preclinical phase was carried out at the Comparative Medicine and Bioimage Centre of Catalonia, a trategic project of IGTP.
The combination of the drug nivolumab with chemotherapy improves survival in patients with high-risk head and neck cancer and could become the new standard treatment, according to the results of an international trial led by professionals from ICO, IGTP and IDIBELL.
The "la Caixa" Foundation has announced the results of the 2025 call for proposals for its CaixaImpulse program, through which it supports 31 biomedical projects from research centres, hospitals and universities in Spain and Portugal. A project coordinated by IIS IGTP led by Ana Piqueras (HUGTiP) has been selected in the call to continue with the development and implementation of a medical device to find and remove cancer cells more accurately during surgery.